![]() |
|
|
DepressionLiteraturAnderson IM, Tomensen BM. Treatment discontinuation with selective Bakish D, Habib R, Hooper CL. Mixed anxiety and Benfield P, Heel RC, Lewis SP. Prozac. Drugs 1986; 481-508. Berber MJ. FINISH: remembering the discontinuation syndrome. J Clin Psychiatry 1998; 59: 255. Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive behavioural therapy in the treatment of generalised anxiety disorder. J Consult Psychol 1993; 61: 611-19. Boyer WF, Feighner JP. Safety and tolerability of SSRIs. In: Feighner JP, Boyer WF (Hrsg.). Selective Deakin, JFW. Does selectivity matter? Int Clin Psychopharmacol 1996; 11 (Suppl 1): 13-17. Datenblatt Faverin. ABPI Data Sheet Compendium 1994-5. Jefferson JW. Antidepressants in panic disorder. J Clin Psychiatry 1997; 58 (Suppl 2): 20-4. Jönson B, Bebbington P. Economic studies of the treatment of depressive illness. In: Jönson B, Rosenbaum J (Hrsg.). Health economics of Joubert A, Sanchez C, Larsen F. Citalopram. Hum Psychopharmacol 2000; 15: 439-51. Datenblatt Lustral. ABPI Data Sheet Compendium 1994-5. Montgomery SA, Kasper S. Side effects, dropouts from treatment and cost consequences. Int Clin Psychopharmacol. 1998; 13 (Suppl 2): S1-5. Noyes R, Garvey MJ, Cook BL. Follow-up study of patients with panic disorder or agoraphobia with panic attacks treated with tricyclic antidepressants. J Affect Disord 1989; 16: 249-57. Datenblatt Prozac. ABPI Data Sheet Compendium 1994-5. Schneier FR, Davies SO, Goetz D, et al. A controlled trial of moclobemide in social phobia. Vortrag anlässlich des Jahrestreffens 1996 der American Psychiatric Association. New York, NY, USA, 8. Mai 1996. Datenblatt Seroxat. ABPI Data Sheet Compendium 1994-5. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||